News

Umbrella Labs has announced an expansion of its BPC-157 peptide offerings, introducing a new liquid spray format designed to improve precision and consistency in laboratory research. This development aims to support preclinical and in vitro investigations by providing a metered dispensing system, thereby reducing variability in experimental outcomes.

Key Takeaways

• Umbrella Labs now offers BPC-157 in a liquid spray format for laboratory research.
• The spray format provides consistent, metered delivery for improved experimental reproducibility.
• BPC-157 is widely studied in preclinical research for tissue repair and gastrointestinal applications.
• Emphasis is placed on quality documentation, lot traceability, and adherence to research-only use.

Enhanced Research Precision

Umbrella Labs' new BPC-157 liquid spray is engineered for laboratories requiring consistent, metered delivery. This format is particularly beneficial for bench workflows where minor variations in handling can significantly impact experimental results. The product is available in two concentrations, 5 mg (50 mcg per spray) and 10 mg (100 mcg per spray), catering to diverse laboratory needs.

Research Context for BPC-157

BPC-157, a peptide derived from gastric juice, is frequently explored in preclinical studies for its potential in regenerative biology, gastrointestinal health, and tissue repair. Research has investigated its effects on tendon and ligament biology, skeletal muscle, bone, and gastrointestinal mucosal integrity. The scientific literature typically frames these findings as mechanistic explorations rather than clinical outcomes.

Quality Control and Documentation

Umbrella Labs highlights its commitment to quality by providing BPC-157 with clear specifications, including CAS Number 137525-51-0, molecular formula, and molecular weight. Purity is stated to be at or above 99 percent by LC-MS. The company also offers access to Certificates of Analysis and Material Safety Data Sheets to support laboratory inventory tracking, documentation, and safety protocols. The product is strictly sold for laboratory developmental research use only.

ProHealth's Approach to Quality Verification

In parallel, ProHealth, a long-standing supplement company, is emphasizing its rigorous quality control for its oral BPC-157 supplements. ProHealth employs a triple third-party lab testing protocol to verify identity, purity, and potency for each batch. This includes screening for contaminants such as heavy metals and microbial pathogens. The company makes Certificates of Authenticity available to customers, aiming to provide transparency in the peptide supplement market.

Sources

• Umbrella Labs BPC157 Liquid Spray Peptide Research Use Only Program Expands Access For High Rigor
  Regenerative Biology, Gastrointestinal, And Tissue Repair Bench Science, Yahoo Finance.
• ProHealth's Triple-Tested Formula Examined as Peptide Quality Verification
  Becomes Consumer Priority Heading Into 2026, Yahoo Finance.